Blair William & Co. IL Boosts Holdings in The Clorox Company (NYSE:CLX)

Blair William & Co. IL grew its position in shares of The Clorox Company (NYSE:CLX) by 1.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,271 shares of the company’s stock after buying an additional 107 shares during the quarter. Blair William & Co. IL’s holdings in Clorox were worth $1,506,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Integral Investment Advisors Inc. raised its holdings in Clorox by 4.1% during the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after purchasing an additional 67 shares in the last quarter. HCR Wealth Advisors increased its position in Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after purchasing an additional 68 shares during the period. Sound View Wealth Advisors Group LLC raised its stake in shares of Clorox by 6.1% during the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock worth $218,000 after buying an additional 77 shares in the last quarter. Brooklyn Investment Group lifted its holdings in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the period. Finally, Global X Japan Co. Ltd. boosted its stake in shares of Clorox by 3.0% in the fourth quarter. Global X Japan Co. Ltd. now owns 3,272 shares of the company’s stock valued at $531,000 after buying an additional 95 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Clorox stock opened at $147.77 on Thursday. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The stock has a fifty day moving average of $150.61 and a two-hundred day moving average of $158.66. The company has a market capitalization of $18.20 billion, a price-to-earnings ratio of 40.37, a PEG ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLX) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the business posted $2.16 earnings per share. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.30%. Clorox’s payout ratio is currently 133.33%.

Analysts Set New Price Targets

A number of equities research analysts have commented on CLX shares. JPMorgan Chase & Co. raised their target price on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Wells Fargo & Company reduced their price objective on shares of Clorox from $161.00 to $155.00 and set an “equal weight” rating for the company in a research note on Wednesday. Evercore ISI upped their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price target on shares of Clorox in a research report on Thursday, January 30th. Finally, DA Davidson decreased their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, Clorox currently has an average rating of “Hold” and an average target price of $159.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.